Trade Bristol Myers ^BMY

Manning & Napier Advisors LLC Decreases Position in Bristol Myers Squibb Company $BMY

LJI Wealth Management LLC Takes $2.11 Million Position in Bristol Myers Squibb Company $BMY

Drucker Wealth 3.0 LLC Makes New $1.12 Million Investment in Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers Squibb accused of buying off competitors to delay development of generic cancer drugs

Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift Accurately

GRIMES & Co WEALTH MANAGEMENT LLC Sells 28,024 Shares of Bristol Myers Squibb Company $BMY - Zolmax

GRIMES & Co WEALTH MANAGEMENT LLC Reduces Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Bought by Generali Asset Management SPA SGR

Bristol Myers Squibb Company $BMY Stock Position Raised by RFG Advisory LLC - Stock Observer

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial

The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It

Premier Fund Managers Ltd Invests $11.63 Million in Bristol Myers Squibb Company $BMY

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

Principal Financial Group Inc. Reduces Stake in Bristol Myers Squibb Company $BMY

6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash

Bokf Na Reduces Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by RNC Capital Management LLC

Truist Financial Corp Trims Stake in Bristol Myers Squibb Company $BMY

Pinnacle Wealth Management Advisory Group LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Shares Bought by Intact Investment Management Inc. - Stock Observer

Christine Messmer PC Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer

In FIFA-Tied Corporate Campaign, Bristol Myers Squibb 'Won't Lose' 05/05/2026

Seizert Capital Partners LLC Acquires 38,725 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026™

M&T Bank Corp Purchases 13,307 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales

A Look At Bristol Myers Squibb (BMY) Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance

BMY: Upcoming Late Stage Readouts Will Drive Potential Re Rating Opportunity

Scotiabank Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY) | Markets Insider

Bristol Myers Squibb Company $BMY Shares Bought by CX Institutional

Bristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of "Hold" by Brokerages - Zolmax

Strs Ohio Sells 46,600 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Robertson Stephens Wealth Management LLC Increases Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Q1 Earnings Call Highlights - Zolmax

Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives

Bristol Myers Squibb Company $BMY Shares Sold by Danske Bank A S

GC Wealth Management RIA LLC Reduces Stake in Bristol Myers Squibb Company $BMY

PFA Pension Forsikringsaktieselskab Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar

Big Pharma M&A set for mega year as patent expiries drive deal urgency

Bristol-Myers Squibb Company (NYSE:BMY) Q1 2026 Earnings Call Transcript

Bristol Myers Squibb Company $BMY Shares Sold by New York State Teachers Retirement System

Is Bristol Myers Squibb (BMY) Still Attractively Priced After Its Strong 1 Year Share Price Gain

Bristol Myers Squibb Q1 Earnings Call Highlights

US Bancorp DE Sells 119,454 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb Co (BMY) Q1 2026 Earnings Call Highlights: Navigating Growth and ...

BMY SWOT Analysis: Financial Resilience Amidst Market Challenges Revealed in 10-Q Filing

GenTrust LLC Takes $778,000 Position in Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers Squibb (NYSE:BMY) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Is Bristol-Myers Squibb Co (BMY) Overvalued After 5.2% Rally? GF Value Says Overvalued

Bristol Myers Squibb (NYSE:BMY) Issues Quarterly Earnings Results - Daily Political

Bristol Myers Squibb Company $BMY Shares Sold by Verity Asset Management Inc.

BMY Forecasts Strong Growth with FY26 Revenue Projections

AI in Clinical Development Summit to Showcase Life Sciences and Technology Leaders Driving Real-World AI Impact | Morningstar

Bristol Myers Squibb (BMY) Q1 2026: EPS $1.31 Beats $1.19 Est., Revenue $11.49B Tops $10. ...

Bristol Myers Squibb Reports First Quarter Financial Results for 2026 | Morningstar

A Look At Bristol Myers Squibb (BMY) Valuation After Upbeat 2026 Guidance And Cost-Cutting Progress

Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomics

Wealthfront Advisers LLC Acquires 21,704 Shares of Bristol Myers Squibb Company $BMY

Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Bristol Myers Squibb Company $BMY Shares Sold by Fagan Associates Inc. - Daily Political

Does Expanded MTAP-CDx Partnership With Foundation Medicine Change The Bull Case For Bristol-Myers Squibb (BMY)?

Evolutionary characterization of lung cancer metastasis

Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

ISM® Honors Farryn Melton with 2026 J. Shipman Gold Medal Award | Morningstar

Bristol Myers Squibb Company $BMY Shares Sold by Skylands Capital LLC

Mitsubishi UFJ Trust & Banking Corp Trims Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Stock Position Reduced by R Squared Ltd

Comerica Bank Decreases Stake in Bristol Myers Squibb Company $BMY

D.A. Davidson & CO. Purchases 28,410 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

BMS patents Ikaros family zinc finger protein degradation inducers | BioWorld

The clinical landscape of HIF2α inhibitors in oncology

Is Bristol Myers Squibb the Best Bargain in Big Pharma?

Aprio Wealth Management LLC Buys 44,125 Shares of Bristol Myers Squibb Company $BMY

The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Vanguard Group Inc. Grows Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Chicago Partners Investment Group LLC

Advisors Capital Management LLC Raises Stake in Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb Precision Oncology Deal Meets Mixed Valuation Signals

Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation

Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation

First Interstate Bank Sells 52,361 Shares of Bristol Myers Squibb Company $BMY

3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

Assessing Bristol Myers Squibb (BMY) Valuation After Recent Earnings Compression And Growth Portfolio Performance

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly

Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Kerusso Capital Management LLC Purchases 12,988 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk